Neuralink’s Brain-Computer Interface (BCI) technology, brain chip, has demonstrated its potential to restore mobility to those with paralysis. However, the brain chip’s technical challenges and ethical dilemmas have begun to surface after its first clinical trial. The human brain and machine connection raises heated ethical discussions about BCI’s potential implications.
View More Neuralink’s Gamble: Public Response After First Clinical Trial’s Failure